NASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis $2.42 -0.12 (-4.72%) Closing price 07/28/2025 04:00 PM EasternExtended Trading$2.46 +0.04 (+1.69%) As of 07/28/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Apyx Medical Stock (NASDAQ:APYX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Apyx Medical alerts:Sign Up Key Stats Today's Range$2.40▼$2.7050-Day Range$1.48▼$2.5852-Week Range$0.76▼$2.73Volume116,885 shsAverage Volume100,753 shsMarket Capitalization$91.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Read More Apyx Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreAPYX MarketRank™: Apyx Medical scored higher than 40% of companies evaluated by MarketBeat, and ranked 696th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Apyx Medical.Read more about Apyx Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -4.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -4.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 6.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Apyx Medical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.64% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently decreased by 2.63%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-1.07 Percentage of Shares Shorted0.64% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently decreased by 2.63%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News Sentiment0.94 News SentimentApyx Medical has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.08 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Apyx Medical this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Apyx Medical's insider trading history. Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address APYX Stock News HeadlinesApyx Medical Corporation Announces Launch of Renuvion® in ChinaJuly 28 at 6:35 PM | finance.yahoo.comApyx Medical Corporation (APYX) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. | Brownstone Research (Ad)Renuvion® Brings Real Transformations to the Runway at Miami Swim WeekMay 30, 2025 | prnewswire.comApyx Medical Announces FDA Clearance For AYON Body Contouring SystemMay 15, 2025 | nasdaq.comApyx Medical wins FDA clearance for body contouring techMay 13, 2025 | finance.yahoo.comApyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™May 13, 2025 | globenewswire.comApyx Medical Corporation (NASDAQ:APYX) Analysts Are Pretty Bullish On The Stock After Recent ResultsMay 11, 2025 | finance.yahoo.comSee More Headlines APYX Stock Analysis - Frequently Asked Questions How have APYX shares performed this year? Apyx Medical's stock was trading at $1.58 at the beginning of 2025. Since then, APYX shares have increased by 53.2% and is now trading at $2.42. How were Apyx Medical's earnings last quarter? Apyx Medical Corporation (NASDAQ:APYX) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.03. The company had revenue of $9.43 million for the quarter, compared to analysts' expectations of $9.39 million. Apyx Medical had a negative net margin of 42.37% and a negative trailing twelve-month return on equity of 156.85%. Read the conference call transcript. Who are Apyx Medical's major shareholders? Top institutional investors of Apyx Medical include Silverberg Bernstein Capital Management LLC (2.37%) and Taylor Frigon Capital Management LLC (1.27%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby. View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/08/2025Today7/28/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:APYX CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees270Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.46 million Net Margins-42.37% Pretax Margin-42.07% Return on Equity-156.85% Return on Assets-31.92% Debt Debt-to-Equity Ratio3.21 Current Ratio5.45 Quick Ratio4.64 Sales & Book Value Annual Sales$48.10 million Price / Sales1.90 Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book6.37Miscellaneous Outstanding Shares37,790,000Free Float32,049,000Market Cap$91.45 million OptionableOptionable Beta1.31 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:APYX) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.